secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDICINOVA INC (MNOV)
CIK:        0001226616
Form:       8-K
Filed at:   2026-06-24T20:38:44+00:00
Accession:  0001193125-26-281171
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

MediciNova shareholders reject proposal to increase authorized shares to 247M at 2026 annual meeting
--------------------------------------------------------------------------------

- Class I directors Hikedi Nagao and Nicole Lemerond elected with ~20.9M and ~21.5M votes for, respectively.
- BDO USA ratified as auditor for FY 2026 with 26.7M votes for, 1.9M against.
- Proposal to increase authorized common shares from 100M to 247M failed with 22.2M for, 6.4M against; needed majority of outstanding shares.
- Adjournment proposal approved with 22.7M for, 5.8M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1226616/000119312526281171/0001193125-26-281171-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1226616/000119312526281171/mnov-20260623.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-281171

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer